Magnesium supplementation prevents experimental chronic cyclosporine A nephrotoxicity via renin-angiotensin system independent mechanism

被引:60
作者
Asai, T
Nakatani, T
Yamanaka, S
Tamada, S
Kishimoto, T
Tashiro, K
Nakao, T
Okamura, M
Kim, S
Iwao, H
Miura, K
机构
[1] Osaka City Univ, Dept Appl Pharmacol & Therapeut, Sch Med, Osaka 5458585, Japan
[2] Osaka City Univ, Sch Med, Dept Pharmacol, Osaka, Japan
[3] Osaka City Univ, Sch Med, Dept Urol, Osaka, Japan
[4] Nara Inst Sci & Technol, Lab Anim Mol Technol, Res & Educ Ctr Genet Informat, Nara, Japan
[5] Osaka City Univ, Sch Med, Dept Internal Med 1, Osaka, Japan
关键词
D O I
10.1097/00007890-200209270-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We have previously shown that, correction of hypomagnesemia by magnesium (Mg) supplementation ameliorates chronic cyclosporine A (CsA) nephropathy via inhibiting gene expression. of fibrogenic molecules. Experiments were conducted to further elucidate upstream mechanism of the beneficial effects upon C&A nephrotoxicity. Methods. CsA (15 mg(kg/day, subcutaneous [SC]) was administered daily to rats maintained on low sodium diet for 7, 14, and 28 days. Because blockade of reninangiotensin system improves chronic CsA nephropathy, the effects of Mg supplementation and those of angiotensin-converting enzyme inhibitor (ACEI) were compared on renal function, renal histology, mononuclear cell infiltration, and gene expression profile. Results. CsA induced a decline in glomerular filtration and developed characteristic striped fibrosis that were mostly evident at day 28. Mg attenuated CsA-induced impaired renal function, whereas ACEI did not. Interstitial inflammation as evidenced by monocyte/macrophage infiltration preceded the renal fibrosis and increased progressively with the CsA treatment period. Concomitantly, CsA markedly upregulated expression of chemoattractant proteins, osteopontin, and monocyte chemoattractant protein-1. These changes were abolished by Mg but were only partially affected with ACEI. CsA promoted renal mRNA expression of fibrogenic molecules and,extracellular matrices that were almost completely abolished by Mg but partially suppressed by ACEI. Similarly, CsA-induced chronic -fibrotic lesion was markedly attenuated by Mg supplementation but was partially attenuated by ACEI. Conclusion. Mg supplementation abolished C&A-induced precedent interstitial inflammation possibly via inhibition of chemoattractants expression and consequently attenuated tubulointerstitial fibrosis. In this protective mechanism, factors independent of the renin-angiotensin system appears to be mainly involved.
引用
收藏
页码:784 / 791
页数:8
相关论文
共 30 条
  • [1] Extracellular matrix-related genes in kidney after ischemic injury:: potential role for TGF-β in repair
    Basile, DP
    Martin, DR
    Hammerman, MR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (06) : F894 - F903
  • [2] Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation
    Bidani, AK
    Griffin, KA
    Bakris, G
    Picken, MM
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (04) : 1651 - 1661
  • [3] PREVENTION OF EXPERIMENTAL CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS BY LOSARTAN AND ENALAPRIL
    BURDMANN, EA
    ANDOH, TF
    NAST, CC
    EVAN, A
    CONNORS, BA
    COFFMAN, TM
    LINDSLEY, J
    BENNETT, WM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 269 (04) : F491 - F499
  • [4] BURDMANN EA, 1994, NEPHROL DIAL TRANSPL, V9, P16
  • [5] TRANSFORMATION OF NIH 3T3-CELLS BY A HUMAN C-SIS CDNA CLONE
    CLARKE, MF
    WESTIN, E
    SCHMIDT, D
    JOSEPHS, SF
    RATNER, L
    WONGSTAAL, F
    GALLO, RC
    REITZ, MS
    [J]. NATURE, 1984, 308 (5958) : 464 - 467
  • [6] Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
    de Mattos, AM
    Olyaei, AJ
    Bennett, WM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) : 333 - 346
  • [7] Mechanism of action and in vivo role of platelet-derived growth factor
    Heldin, CH
    Westermark, B
    [J]. PHYSIOLOGICAL REVIEWS, 1999, 79 (04) : 1283 - 1316
  • [8] Osteopontin expression in human cyclosporine toxicity
    Hudkins, KL
    Le, QC
    Segerer, S
    Johnson, RJ
    Davis, CL
    Giachelli, CM
    Alpers, CE
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (02) : 635 - 640
  • [9] Ivacko J, 1997, J CEREBR BLOOD F MET, V17, P759
  • [10] KAYE M, 1974, J LAB CLIN MED, V84, P536